Literature DB >> 19535911

Micromanipulating cancer: microRNA-based therapeutics?

Fabio Petrocca1, Judy Lieberman.   

Abstract

Because microRNAs regulate cancer cell differentiation, proliferation, survival and metastasis, manipulating microRNA function, either by mimicking or inhibiting miRNAs implicated in cancer, could provide a powerful therapeutic strategy to interfere with key pathways for cancer progression. This review will explore some of the opportunities and obstacles to harnessing microRNA biology for cancer therapy.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19535911     DOI： 10.4161/rna.6.3.9013

Source DB:  PubMed          Journal:  RNA Biol        ISSN： 1547-6286            Impact factor:   4.652


  14 in total

Review 1.  Prospects of miRNA-based therapy for pancreatic cancer.

Authors:  Priya Pai; Satyanarayana Rachagani; Chandrakanth Are; Surinder K Batra
Journal:  Curr Drug Targets       Date:  2013-09       Impact factor: 3.465

2.  Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.

Authors:  Jason F Wiggins; Lynnsie Ruffino; Kevin Kelnar; Michael Omotola; Lubna Patrawala; David Brown; Andreas G Bader
Journal:  Cancer Res       Date:  2010-06-22       Impact factor: 12.701

Review 3.  RNA-binding protein nucleolin in disease.

Authors:  Kotb Abdelmohsen; Myriam Gorospe
Journal:  RNA Biol       Date:  2012-05-23       Impact factor: 4.652

4.  MicroRNAs-10a and -10b contribute to retinoic acid-induced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2/ASF).

Authors:  Salvador Meseguer; Giridhar Mudduluru; Juan Manuel Escamilla; Heike Allgayer; Domingo Barettino
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

5.  MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer.

Authors:  Nicole M A White; George M Yousef
Journal:  BMC Med       Date:  2010-10-21       Impact factor: 8.775

6.  miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in vitro and in vivo.

Authors:  Mrinmay Chakrabarti; Naren L Banik; Swapan K Ray
Journal:  Exp Cell Res       Date:  2013-04-03       Impact factor: 3.905

Review 7.  MicroRNA therapeutics.

Authors:  J A Broderick; P D Zamore
Journal:  Gene Ther       Date:  2011-04-28       Impact factor: 5.250

8.  The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer.

Authors:  Wei-Cheng Liang; Wei-Ming Fu; Cheuk-Wa Wong; Yan Wang; Wei-Mao Wang; Guo-Xin Hu; Li Zhang; Li-Jia Xiao; David Chi-Cheong Wan; Jin-Fang Zhang; Mary Miu-Yee Waye
Journal:  Oncotarget       Date:  2015-09-08

Review 9.  XenomiRs and miRNA homeostasis in health and disease: evidence that diet and dietary miRNAs directly and indirectly influence circulating miRNA profiles.

Authors:  Kenneth W Witwer
Journal:  RNA Biol       Date:  2012-09-01       Impact factor: 4.652

10.  microRNA-106a modulates cisplatin sensitivity by targeting PDCD4 in human ovarian cancer cells.

Authors:  Hao Li; Haiyuan Xu; Huiling Shen; Hao Li
Journal:  Oncol Lett       Date:  2013-10-29       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.